What Would You Do? Engaging in Evidence-based Treatment Approaches for Multiple Sclerosis

What Would You Do? Engaging in Evidence-based Treatment Approaches for Multiple Sclerosis

Decision-making in multiple sclerosis (MS) care is as complex as the disease itself. Understanding of the inflammatory and neurodegenerative processes implicated in disease activity and progression continues to improve. At the same time, technology is constantly progressing. These advances are driving changes in the way MS is viewed and managed across the continuum of disease. As evidence evolves, clinicians look to experts for guidance and best practices. This case-based, interactive session is designed to highlight current challenges in the diagnosis, treatment, and monitoring of people with MS. Expert faculty will present cases, discuss relevant evidence, explore options, and provide their answers to the question what would you do?

  • Provider:Consortium of Multiple Sclerosis Centers
  • Activity Link: https://www.freecme.com/products/what-would-you-do-engaging-in-evidence-based-treatment-approaches-for-multiple-sclerosis
  • Start Date: 2024-06-28 05:00:00
  • End Date: 2024-06-28 05:00:00
  • Credit Details: IPCE Credits: 1.5 hours
    AMA PRA Category 1 Credit™️: 1.5 hours
    Nursing: 1.5 hours
    Pharmacy: 1.5 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner/Team Competence
  • Provider Ship: Jointly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.